Skip to main content

COMPASS Pathways plc

CMPS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001816590

No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding COMPASS Pathways plc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CMPS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders103197−5
Shares8.18M408.30M+112.8K (+1.4%)
Value$81.3M$0$68.7M−$12.6M (−15.5%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held COMPASS Pathways plc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CMPS in Q2 2023
InstitutionSharesValue% of portfolio
Deep Track Capital, LP678,360$5.62M0.26%
Lynx1 Capital Management LP20,114$166.5K0.11%
TAP Consulting, LLC11,200$92.7K0.02%
Oppenheimer & Co Inc10,366$85.8K0.00%
Cubist Systematic Strategies, LLC10,322$85.5K0.00%
Simplex Trading, LLC2,127$17.0K0.00%
First Manhattan Co1,200$9.94K0.00%
Rhumbline Advisers585$4.84K0.00%
Northwestern Mutual Wealth Management Co483$4.00K0.00%
GHP Investment Advisors, Inc.250$2.03K0.00%
Impact Partnership Wealth, LLC40$3310.00%
Tradewinds Capital Management, LLC14$1160.00%
Ronald Blue Trust, Inc.4$00.00%

Sold out (18)

Institutions that held COMPASS Pathways plc at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held COMPASS Pathways plc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CMPS in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Baldrige Asset Management LLC40$0